Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Centre for Colorectal Disease, St Vincent's University Hospital, Dublin, Ireland.
Br J Surg. 2019 Nov;106(12):1697-1704. doi: 10.1002/bjs.11259. Epub 2019 Aug 8.
Appendicectomy may reduce relapses and need for medication in patients with ulcerative colitis, but long-term prospective data are lacking. This study aimed to analyse the effect of appendicectomy in patients with refractory ulcerative colitis.
In this prospective multicentre cohort series, all consecutive patients with refractory ulcerative colitis referred for proctocolectomy between November 2012 and June 2015 were counselled to undergo laparoscopic appendicectomy instead. The primary endpoint was clinical response (reduction of at least 3 points in the partial Mayo score) at 12 months and long-term follow-up. Secondary endpoints included endoscopic remission (endoscopic Mayo score of 1 or less), failure (colectomy or start of experimental medication), and changes in Inflammatory Bowel Disease Questionnaire (IBDQ) (range 32-224), EQ-5D™ and EORTC-QLQ-C30-QL scores.
A total of 28 patients (13 women; median age 40·5 years) underwent appendicectomy. The mean baseline IBDQ score was 127·0, the EQ-5D™ score was 0·65, and the EORTC-QLQ-C30-QL score was 41·1. At 12 months, 13 patients had a clinical response, five were in endoscopic remission, and nine required a colectomy (6 patients) or started new experimental medical therapy (3). IBDQ, EQ-5D™ and EORTC-QLQ-C30-QL scores improved to 167·1 (P < 0·001), 0·80 (P = 0·003) and 61·0 (P < 0·001) respectively. After a median of 3·7 (range 2·3-5·2) years, a further four patients required a colectomy (2) or new experimental medical therapy (2). Thirteen patients had a clinical response and seven were in endoscopic remission. The improvement in IBDQ, EQ-5D™ and the EORTC-QLQ-C30-QL scores remained stable over time.
Appendicectomy resulted in a clinical response in nearly half of patients with refractory ulcerative colitis and a substantial proportion were in endoscopic remission. Elective appendicectomy should be considered before proctocolectomy in patients with therapy-refractory ulcerative colitis.
阑尾切除术可能会降低溃疡性结肠炎患者的复发率和药物治疗的需求,但缺乏长期前瞻性数据。本研究旨在分析阑尾切除术对难治性溃疡性结肠炎患者的影响。
在这项前瞻性多中心队列研究中,所有在 2012 年 11 月至 2015 年 6 月期间因难治性溃疡性结肠炎接受直肠结肠切除术的患者均被建议接受腹腔镜阑尾切除术。主要终点是 12 个月时的临床反应(部分 Mayo 评分至少降低 3 分)和长期随访。次要终点包括内镜缓解(内镜 Mayo 评分 1 或更低)、失败(结肠切除术或开始实验性药物治疗)以及炎症性肠病问卷(IBDQ)(范围 32-224)、EQ-5D 评分和 EORTC-QLQ-C30-QL 评分的变化。
共有 28 例患者(13 例女性;中位年龄 40.5 岁)接受了阑尾切除术。基线时 IBDQ 评分平均为 127.0,EQ-5D 评分为 0.65,EORTC-QLQ-C30-QL 评分为 41.1。12 个月时,13 例患者有临床反应,5 例患者内镜缓解,9 例需要结肠切除术(6 例)或开始新的实验性药物治疗(3 例)。IBDQ、EQ-5D 和 EORTC-QLQ-C30-QL 评分分别提高至 167.1(P<0.001)、0.80(P=0.003)和 61.0(P<0.001)。中位随访 3.7 年后(范围 2.3-5.2 年),4 例患者再次需要结肠切除术(2 例)或新的实验性药物治疗(2 例)。13 例患者有临床反应,7 例患者内镜缓解。IBDQ、EQ-5D 和 EORTC-QLQ-C30-QL 评分的改善在随访期间保持稳定。
阑尾切除术使近一半难治性溃疡性结肠炎患者获得临床反应,相当一部分患者达到内镜缓解。对于治疗抵抗的溃疡性结肠炎患者,在接受直肠结肠切除术之前应考虑选择性阑尾切除术。